Stay updated on Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page
- Check6 days agoChange DetectedVersion 67 (2025-12-23) adds Contacts/Locations and Study Status to the record history. A deletion occurred on 2025-11-26.SummaryDifference0.2%

- Check13 days agoChange DetectedRevision updated to v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA new version (v3.3.2) was added on 2025-11-26 with updated Contacts/Locations and Study Status. The prior version (v3.3.1) from 2025-10-29 was superseded.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1; this is a backend version change with no impact on study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page no longer displays the general government funding/operating status notice; this banner removal is non-critical and does not affect the study data or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedLatest version adds a Contacts/Locations section and a Study Status entry to the record. A prior entry dated 2025-09-18 was removed.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.